These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 10611410)
1. The role of chemokines in the immunopathology of pulmonary disease. Kunkel SL; Lukacs NW; Strieter RM; Chensue SW Forum (Genova); 1999; 9(4):339-55. PubMed ID: 10611410 [TBL] [Abstract][Full Text] [Related]
2. [Recent advances on the role of chemokines/chemokine receptors in the pathogenesis of idiopathic pulmonary fibrosis]. Brunetti G; Pignatti P Recenti Prog Med; 2007 Feb; 98(2):90-6. PubMed ID: 17439069 [TBL] [Abstract][Full Text] [Related]
3. Targeting the chemokine network in renal inflammation. Eis V; Vielhauer V; Anders HJ Arch Immunol Ther Exp (Warsz); 2004; 52(3):164-72. PubMed ID: 15247883 [TBL] [Abstract][Full Text] [Related]
4. Role of chemokines in the pathogenesis of asthma. Lukacs NW Nat Rev Immunol; 2001 Nov; 1(2):108-16. PubMed ID: 11905818 [TBL] [Abstract][Full Text] [Related]
5. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection. Zeremski M; Petrovic LM; Talal AH J Viral Hepat; 2007 Oct; 14(10):675-87. PubMed ID: 17875002 [TBL] [Abstract][Full Text] [Related]
6. [Role of chemokine receptors in allergic inflammation and new potential of treatment of bronchial asthma]. D'Ambrosio D Recenti Prog Med; 2002 Jun; 93(6):346-50. PubMed ID: 12085712 [TBL] [Abstract][Full Text] [Related]
7. The therapeutic potential in targeting CCR5 and CXCR4 receptors in infectious and allergic pulmonary disease. Hogaboam CM; Carpenter KJ; Schuh JM; Proudfoot AA; Bridger G; Buckland KF Pharmacol Ther; 2005 Sep; 107(3):314-28. PubMed ID: 16009428 [TBL] [Abstract][Full Text] [Related]
8. III. Chemokines and other mediators, 8. Chemokines and their receptors in cell-mediated immune responses in the lung. Matsukawa A; Lukacs NW; Hogaboam CM; Chensue SW; Kunkel SL Microsc Res Tech; 2001 May; 53(4):298-306. PubMed ID: 11340675 [TBL] [Abstract][Full Text] [Related]
9. [The role of chemokines in ocular diseases. Part II. Participation of chemokines in ocular diseases]. Malesiński R; Mrugacz M; Bakunowicz-Łazarczyk A Klin Oczna; 2007; 109(7-9):345-8. PubMed ID: 18260295 [TBL] [Abstract][Full Text] [Related]
10. Chemokine-like factor 1, a novel cytokine, contributes to airway damage, remodeling and pulmonary fibrosis. Tan YX; Han WL; Chen YY; Ouyang NT; Tang Y; Li F; Ding PG; Ren XL; Zeng GQ; Ding J; Zhu T; Ma DL; Zhong NS Chin Med J (Engl); 2004 Aug; 117(8):1123-9. PubMed ID: 15361282 [TBL] [Abstract][Full Text] [Related]
11. Pathogenic T-cell recruitment into the airway in human disease. Medoff BD; Thomas SY; Banerji A; Wain JC; Zhang H; Lilly CM; Ginns LC; Luster AD Ann N Y Acad Sci; 2005 Dec; 1062():220-41. PubMed ID: 16461804 [TBL] [Abstract][Full Text] [Related]
12. Chemokines and chemokine receptors in HIV infection: role in pathogenesis and therapeutics. Suresh P; Wanchu A J Postgrad Med; 2006; 52(3):210-7. PubMed ID: 16855325 [TBL] [Abstract][Full Text] [Related]
13. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Cartier L; Hartley O; Dubois-Dauphin M; Krause KH Brain Res Brain Res Rev; 2005 Feb; 48(1):16-42. PubMed ID: 15708626 [TBL] [Abstract][Full Text] [Related]
14. CXCR2 antagonists for the treatment of pulmonary disease. Chapman RW; Phillips JE; Hipkin RW; Curran AK; Lundell D; Fine JS Pharmacol Ther; 2009 Jan; 121(1):55-68. PubMed ID: 19026683 [TBL] [Abstract][Full Text] [Related]
17. [Blockade of chemokines in chronic inflammatory diseases]. Haringman JJ; Tak PP Ned Tijdschr Geneeskd; 2004 Sep; 148(36):1760-4. PubMed ID: 15495938 [TBL] [Abstract][Full Text] [Related]
18. A burgeoning family of biological mediators: chemokines and chemokine receptors. Le Y; Gong W; Shen W; Li B; Dunlop NM; Wang JM Arch Immunol Ther Exp (Warsz); 2000; 48(3):143-50. PubMed ID: 10912618 [TBL] [Abstract][Full Text] [Related]
19. Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components. Chen X; Oppenheim JJ; Howard OM Cell Mol Immunol; 2004 Oct; 1(5):336-42. PubMed ID: 16285892 [TBL] [Abstract][Full Text] [Related]
20. In vivo gene silencing (with siRNA) of pulmonary expression of MIP-2 versus KC results in divergent effects on hemorrhage-induced, neutrophil-mediated septic acute lung injury. Lomas-Neira JL; Chung CS; Wesche DE; Perl M; Ayala A J Leukoc Biol; 2005 Jun; 77(6):846-53. PubMed ID: 15695553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]